Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Cameron
LBA40_PRARIEL3: A Phase 3, Randomised, Double-Blind Study of Rucaparib vs Placebo Following Response to Platinum-Based Chemotherapy for Recurrent Ovarian Carcinoma (OC)
Annals of Oncology
Medicine
Oncology
Hematology
Natural Enemy Specialization and the Period of Population Cycles
Ecology Letters
Evolution
Ecology
Systematics
Behavior
Related publications
ENGOT-ov-6/TRINOVA-2: Randomised, Double-Blind, Phase 3 Study of Pegylated Liposomal Doxorubicin Plus Trebananib or Placebo in Women With Recurrent Partially Platinum-Sensitive or Resistant Ovarian Cancer
European Journal of Cancer
Cancer Research
Oncology
Pazopanib for Metastatic Soft-Tissue Sarcoma (PALETTE): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
The Lancet
Medicine
Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive, Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial
The Lancet Oncology
Oncology
Adjunctive Everolimus Therapy for Treatment-Resistant Focal-Onset Seizures Associated With Tuberous Sclerosis: A Phase 3, Randomised, Double-Blind, Placebo-Controlled Study
Turk Noroloji Dergisi
Neurology
Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial
The Lancet
Medicine
Chemotherapy-Free Strategy for Platinum-Sensitive Recurrent Ovarian Cancer
The Lancet Oncology
Oncology
Curcumin for the Treatment of Major Depression: A Randomised, Double-Blind, Placebo Controlled Study
Journal of Affective Disorders
Psychiatry
Clinical Psychology
Mental Health
Sarilumab for the Treatment of Ankylosing Spondylitis: Results of a Phase II, Randomised, Double-Blind, Placebo-Controlled Study (ALIGN)
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Donepezil for Dementia in Parkinson's Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
